Skip to content

Effect of leech therapy along with Patolakaturohinyadi Kashaya internally and washing with triphala kashaya externally in Varicose Eczema

Clinical study to evaluate the effect of Jalaukavacharana along with Patolakaturohinyadi kashaya and Triphala kashaya kshalana in Varicose eczema - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072431
Enrollment
32
Registered
2024-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I838- Varicose veins of lower extremities with other complications

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects of age group between 30-70 years irrespective of gender, religion, occupation and socio-economic status. 2. Subjects with signs and symptoms of Varicose eczema. 3. Subjects willing to sign the consent form

Exclusion criteria

Exclusion criteria: 1. Subjects using anticoagulants and blood thinners. 2. Subjects having uncontrolled Diabetes Mellitus. 3. Subjects contraindicated for Rakthamokshana 4. Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
1. To assess the effect of Jalaukavacharana along with Patolakaturohinyadi kashaya internally and Triphala kashaya kshalana in the management of Varicose eczema. 2. To find out the effect of Jalaukavacharana along with Patolakaturohinyadi kashaya internally and Triphala kashaya kshalana in reducing signs and symptoms of Varicose eczema using Patient-Oriented Eczema Measure (POEM). 3. To evaluate the effect of Jalaukavacharana along with Patolakaturohinyadi kashaya internally and Triphala kashaya kshalana in improving quality of life in Varicose Eczema using Dermatology life quality index (DLQI)..Timepoint: 1. Clinical assessment of signs and symptoms of Varicose eczema will be done on 0th, 11th, 21st and 30th day. Follow up will be done on 30th and 45th day. 2. Assessment of severity of Varicose eczema in an individual using Patient-Oriented Eczema Measure (POEM) on 0th, 11th, 21st and 30th day. 2. Assessment of the quality of life in an individual using Dermatology Life Quality Index (DLQI) on 0th, 11th, 21st and 30th day.

Secondary

MeasureTime frame
To evaluate the safety of Jalaukavacharana in subjects with Varicose eczema. Haemoglobin & Erythrocyte Sedimentation Rate will be done to assess the safety.Timepoint: Safety parameters will be assessed on 1st & 21st day

Countries

India

Contacts

Public ContactKaveri S

Pankajakasthuri Ayurveda Medical College and Post Graduate Center

kaverisekharan5@gmail.com6282363504

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026